Pau Abrisqueta

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada et al. · Journal of Clinical Oncology · 2017 · 414 citations

Advanced-stage Dlbcl, Lymphoid Neoplasia, Hematological Malignancy +13

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

David W. Scott, Anja Mottok, Daisuke Ennishi et al. · Journal of Clinical Oncology · 2015 · 390 citations · Full text

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas et al. · Blood · 2019 · 229 citations · Full text

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

Eva Giné, N. Villamor, Armando López‐Guillermo et al. · Haematologica · 2010 · 194 citations · Full text

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

Neus Villamor, L Conde, Alejandra Martínez‐Trillos et al. · Leukemia · 2012 · 183 citations · Full text

Hematological Malignancy, Notch1 Mutations, Genetics +7